Atlas Venture Life Science Advisors, LLC Dyne Therapeutics, Inc. Put Options Transaction History
Atlas Venture Life Science Advisors, LLC
- $341 Million
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding DYN
# of Institutions
216Shares Held
116MCall Options Held
322KPut Options Held
66.2K-
Janus Henderson Group PLC London, X010.4MShares$147 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA9.71MShares$138 Million2.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.41MShares$105 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$105 Million0.01% of portfolio
-
Fcpm Iii Services B.V. Naarden, P75.46MShares$77.7 Million13.81% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $737M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...